In addition, PSMD13 significantly decreased in the lesioned skin of vitiligo patients, suggesting that PSMD13 is involved in the skin lesion development process through the NOD-like-receptor signalling pathway, but HMGA1 did not significantly decrease in the lesioned skin. This evidence concerns the gene PSMD13 and vitiligo.